<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31865354</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0208</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Neuroepidemiology</Title><ISOAbbreviation>Neuroepidemiology</ISOAbbreviation></Journal><ArticleTitle>A Standard Framework for Population-Based Neuroepidemiological Studies in Tropical Low- and Middle-Income Countries.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>105</EndPage><MedlinePgn>96-105</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000503235</ELocationID><Abstract><AbstractText>Methodologies of population-based studies on neurological diseases in low- and middle-income countries (LMICs) have not been standardized. The objective of this paper is to provide an overview of the numerous challenges occurring in this context and propose a standard framework for population-based studies in LMICs. We relied on our expertise on few diseases, epilepsy and neurodegenerative disorders. The proposed framework is the result of extensive field experience in tropical LMICs. It ensures that important steps are not forgotten when setting up a study plan. It must remain flexible and be adapted to each situation, to the disease studied, in particular its prevalence, but also to the geography of the study area and the availability of survey technologies.</AbstractText><CopyrightInformation>&#xa9; 2019 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boumediene</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>INSERM, U1094, Tropical Neuroepidemiology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Limoges, U1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>INSERM, U1094, Tropical Neuroepidemiology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Limoges, U1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auditeau</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>INSERM, U1094, Tropical Neuroepidemiology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Limoges, U1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Limoges, Centre d'Epid&#xe9;miologie de Biostatistique et de M&#xe9;thodologie de la Recherche, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jost</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>INSERM, U1094, Tropical Neuroepidemiology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Limoges, U1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Limoges, Department of Pharmacy, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerchet</LastName><ForeName>Ma&#xeb;lenn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM, U1094, Tropical Neuroepidemiology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Limoges, U1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, Limoges, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London, Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preux</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>INSERM, U1094, Tropical Neuroepidemiology, Limoges, France, preux@unilim.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Limoges, U1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, Limoges, France, preux@unilim.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Limoges, Centre d'Epid&#xe9;miologie de Biostatistique et de M&#xe9;thodologie de la Recherche, Limoges, France, preux@unilim.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neuroepidemiology</MedlineTA><NlmUniqueID>8218700</NlmUniqueID><ISSNLinking>0251-5350</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015340" MajorTopicYN="Y">Epidemiologic Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016021" MajorTopicYN="Y">Epidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014329" MajorTopicYN="N">Tropical Climate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Epilepsy</Keyword><Keyword MajorTopicYN="N">Framework</Keyword><Keyword MajorTopicYN="N">Low- and middle-income countries</Keyword><Keyword MajorTopicYN="N">Methodology</Keyword><Keyword MajorTopicYN="N">Population-based study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31865354</ArticleId><ArticleId IdType="doi">10.1159/000503235</ArticleId><ArticleId IdType="pii">000503235</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>